Additionally, uptake of DC‐derived (EVs) by breast cancer cells can augment the activation of tumour‐sensitised T cells to secrete IFN‐γ for promoting a more potent tumour‐specific immune response [84]. This evidence concerns the gene IFNG and neoplasm.